Literature DB >> 11390620

Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host.

A Abendroth1, G Morrow, A L Cunningham, B Slobedman.   

Abstract

During primary varicella-zoster virus (VZV) infection, it is presumed that virus is transmitted from mucosal sites to regional lymph nodes, where T cells become infected. The cell type responsible for VZV transport from the mucosa to the lymph nodes has not been defined. In this study, we assessed the susceptibility of human monocyte-derived dendritic cells to infection with VZV. Dendritic cells were inoculated with the VZV strain Schenke and assessed by flow cytometry for VZV and dendritic cell (CD1a) antigen expression. In five replicate experiments, 34.4% +/- 6.6% (mean +/- SEM) of CD1a(+) cells were also VZV antigen positive. Dendritic cells were also shown to be susceptible to VZV infection by the detection of immediate-early (IE62), early (ORF29), and late (gC) gene products in CD1a(+) dendritic cells. Infectious virus was recovered from infected dendritic cells, and cell-to-cell contact was required for transmission of virus to permissive fibroblasts. VZV-infected dendritic cells showed no significant decrease in cell viability or evidence of apoptosis and did not exhibit altered cell surface levels of major histocompatibility complex (MHC) class I, MHC class II, CD86, CD40, or CD1a. Significantly, when autologous T lymphocytes were incubated with VZV-infected dendritic cells, VZV antigens were readily detected in CD3(+) T lymphocytes and infectious virus was recovered from these cells. These data provide the first evidence that dendritic cells are permissive to VZV and that dendritic cell infection can lead to transmission of virus to T lymphocytes. These findings have implications for our understanding of how virus may be disseminated during primary VZV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390620      PMCID: PMC114334          DOI: 10.1128/JVI.75.13.6183-6192.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

2.  Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.

Authors:  A Blauvelt; H Asada; M W Saville; V Klaus-Kovtun; D J Altman; R Yarchoan; S I Katz
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  Dendritic cell development and maturation.

Authors:  R M Steinman; M Pack; K Inaba
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

4.  Differential infection of CD34+ cell-derived dendritic cells and monocytes with lymphocyte-tropic and monocyte-tropic HIV-1 strains.

Authors:  M K Warren; W L Rose; J L Cone; W G Rice; J A Turpin
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

5.  Apoptosis as a mechanism of peripheral blood mononuclear cell death after measles and varicella-zoster virus infections in children.

Authors:  C Pignata; M Fiore; S de Filippo; M Cavalcanti; L Gaetaniello; I Scotese
Journal:  Pediatr Res       Date:  1998-01       Impact factor: 3.756

6.  HIV-infected Langerhans cells constitute a significant proportion of the epidermal Langerhans cell population throughout the course of HIV disease.

Authors:  C C Compton; T S Kupper; K B Nadire
Journal:  J Invest Dermatol       Date:  1996-12       Impact factor: 8.551

7.  Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.

Authors:  P Brossart; M J Bevan
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

Review 8.  Interactions of viruses with dendritic cells: a double-edged sword.

Authors:  N Bhardwaj
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

9.  Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells.

Authors:  I Grosjean; C Caux; C Bella; I Berger; F Wild; J Banchereau; D Kaiserlian
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

10.  Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells.

Authors:  I Fugier-Vivier; C Servet-Delprat; P Rivailler; M C Rissoan; Y J Liu; C Rabourdin-Combe
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

View more
  46 in total

1.  Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.

Authors:  Gavin Morrow; Barry Slobedman; Anthony L Cunningham; Allison Abendroth
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.

Authors:  Cindy Gutzeit; Martin J Raftery; Matthias Peiser; Karsten B Tischer; Martina Ulrich; Melanie Eberhardt; Eggert Stockfleth; Thomas Giese; Andreas Sauerbrei; Craig T Morita; Günther Schönrich
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

3.  Infection and Functional Modulation of Human Monocytes and Macrophages by Varicella-Zoster Virus.

Authors:  Megan Steain; Barry Slobedman; Allison Abendroth; Jarrod J Kennedy
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

Review 4.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

5.  Simian Varicella Virus Is Present in Macrophages, Dendritic Cells, and T Cells in Lymph Nodes of Rhesus Macaques after Experimental Reactivation.

Authors:  Vicki Traina-Dorge; Lara A Doyle-Meyers; Robert Sanford; Jennifer Manfredo; Anna Blackmon; Mary Wellish; Stephanie James; Xavier Alvarez; Cecily Midkiff; Brent E Palmer; Eileen Deharo; Don Gilden; Ravi Mahalingam
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 6.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 7.  Molecular mechanisms of varicella zoster virus pathogenesis.

Authors:  Leigh Zerboni; Nandini Sen; Stefan L Oliver; Ann M Arvin
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

8.  Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.

Authors:  Ann Chahroudi; David A Garber; Patrick Reeves; Luzheng Liu; Daniel Kalman; Mark B Feinberg
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 9.  Dendritic cells in viral pathogenesis: protective or defective?

Authors:  Gabriele Pollara; Antonia Kwan; Philippa J Newton; Matthew E Handley; Benjamin M Chain; David R Katz
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

10.  Receptor-dependent coronavirus infection of dendritic cells.

Authors:  Brian C Turner; Erin M Hemmila; Nicole Beauchemin; Kathryn V Holmes
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.